Cannabinoids: from pot to lab
Abstract Cannabis is becoming increasingly present in our society. In recent years, the line between the natural (cannabis) and the…
Cannabidiol (CBD)
Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain
Abstract Chronic neuropathic pain is a prevalent condition that places a heavy burden on individuals and the healthcare system. Current…
Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs
Abstract Glioblastoma (GBM) is the most malignant brain tumor and one of the deadliest types of solid cancer overall. Despite…
Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases
Abstract Purpose: The aim of this review was to assess the efficacy of cannabis preparations for relieving pain in patients…
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
Abstract The interest in cannabis-based products for the treatment of refractory epilepsy has skyrocketed in recent years. Marijuana and other…
Cannabis sativa (Hemp) Seeds, Δ9-Tetrahydrocannabinol, and Potential Overdose
Abstract Introduction:Cannabis sativa (hemp) seeds are popular for their high nutrient content, and strict regulations are in place to limit…
Medical marijuana for the treatment of vismodegib-related muscle spasm
Keywords: basal cell carcinoma, medical marijuana, muscle cramps, vismodegib, BCC, basal cell carcinoma, CBD, cannabidiol, FDA, US Food and Drug…
An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
Abstract Cannabidiol (CBD) has been traditionally used in Cannabis-based preparation, however historically, it has received far less interest as a…
Targeting calcium signaling in cancer therapy
Abstract The intracellular calcium ions (Ca2+) act as second messenger to regulate gene transcription, cell proliferation, migration and death. Accumulating…
Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders
Abstract Anxiety and trauma-related disorders are psychiatric diseases with a lifetime prevalence of up to 25%. Phobias and post-traumatic stress…